Sterling Investment Advisors (Pennsylvania)’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,000	Closed	-$16K	–	493
2022 Q2	$16K	Hold	2,000	–	–	0.01%	350
2022 Q1	$17K	Hold	2,000	–	–	﹤0.01%	379
2021 Q4	$19K	Hold	2,000	–	–	0.01%	374
2021 Q3	$34K	Buy	+2,000	New	+$34K	0.01%	297